BENSALEM, Pa.--(EON: Enhanced Online News)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of Insys Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY) investors concerning the Company and its officers’ possible violations of federal securities laws.
On March 15, 2017, Insys disclosed that it would delay the release of its financial results for the fourth quarter and full year 2016 in order to complete an independent review of the Company’s processes related to sales allowances and extended payment terms. The company further disclosed that the review could result in a reduction of 2015 net revenue and pre-tax income.
On this news, shares of Insys fell approximately 5% during intraday trading on March 16, 2017, thereby injuring investors.
If you purchased Insys securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.